Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trialSteven M. Horwitz, June Weon Cheong, Owen A. O’Connor et al.|The Lancet|2018Cited by 733
Intracellular Retention of the MHC Class I-Related Chain B Ligand of NKG2D by the Human Cytomegalovirus UL16 GlycoproteinJennifer D. Wu, Thomas A. Spies, N. Jan Chalupny et al.|The Journal of Immunology|2003Cited by 140
MULTIDRUG-RESISTANT ENTEROCOCCUS FAECIUM MENINGITIS IN A TODDLERHeather B. Jaspan, Scott J. Weissman, Adam Brothers et al.|The Pediatric Infectious Disease Journal|2010Cited by 80
A phase I study of panobinostat in children with relapsed and refractory hematologic malignanciesJulio C. Barredo, Maria Luisa Sulis, Julia Glade Bender et al.|Pediatric Hematology and Oncology|2020Cited by 24
A Phase I Dose Finding Study of Panobinostat in Children with Hematologic Malignancies: Initial Report of TACL Study T2009-012 in Children with Acute LeukemiaJohn M. Goldberg, Julio C. Barredo, Julia Glade Bender et al.|Blood|2014Cited by 11